FLT3 and neoplasm: The FLT3 ligand is also expressed in hematopoietic cells, and is thought to contribute to the immune response via the stimulation of early B-cells, dendritic cells, and natural killer cells; it is thought that this immune response may predict an anti-tumor effect [12].